BDMD
Baird Medical Investment Holdings Ltd
$1.18
▲ +3.51%$1.18▼ -73.30%
over 1Y
L $0.77EODHDH $4.42
Today+3.5%
1W+19.2%
1M-11.9%
3M-39.5%
YTD-11.9%
1Y-73.3%
Avoid
Conviction
Horizon
Medium (3–12mo)
Revenue fell -39.2% YoY.
Revenue (FY2025) $22.5M · FY2025
Baird Medical Investment Holdings Ltd shows $22.5M in FY2025 revenue (-39.2% YoY), a -121.0% net margin, and -87.0% ROE.
Weighing against it: revenue fell -39.2% YoY; unprofitable (net margin -121.0%).
Financials · annual, by fiscal year
| Line item | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|
| Revenue | $35.1M | $31.5M | $37.0M | $22.5M |
| Gross profit | $28.0M | $27.2M | $32.7M | $18.9M |
| Operating income | $13.6M | $11.9M | $15.3M | -$25.6M |
| Net income | — | $10.5M | $12.5M | -$27.3M |
| Diluted EPS | $0.49 | $0.51 | $0.57 | -$0.98 |
| Net margin | — | 33.5% | 33.6% | -121.0% |
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Key statistics
Valuation
Enterprise value$46.3M
EV / EBITDA—
EV / Sales2.1
EV / FCF—
P / FCF—
PEG (trailing)—
Earnings yield-72.3%
FCF yield-3.7%
Quality & risk
ROIC (est.)-50.5%
Free cash flow-$1.39M
Total debt$8.72M
Net cash-$8.54M
Altman Z-Score0.08 distress
Piotroski F-Score1/9
Capital returns
Buyback yield—
Dividend yield (est.)—
Shareholder yield—
Shares Δ YoY+14.7%
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
Recent filings
all on EDGAR ↗POS AMFiling2026-05-22open ↗F-3Filing2026-05-22open ↗SCHEDULE 13GFiling2026-05-08open ↗20-FPeriod ending 2025-12-312026-04-24open ↗3Period ending 2026-04-212026-04-21open ↗3Period ending 2026-04-212026-04-21open ↗3Period ending 2026-04-212026-04-21open ↗3Period ending 2026-03-182026-04-17open ↗3Period ending 2026-04-152026-04-15open ↗3Period ending 2026-03-182026-03-31open ↗3Period ending 2026-03-312026-03-31open ↗3Period ending 2026-03-272026-03-27open ↗
Frequently asked
- Is Baird Medical Investment Holdings Ltd (BDMD) a buy?
- BDMD currently carries a Avoid rating with 4/5 conviction, derived from its latest SEC filings. Revenue fell -39.2% YoY.
- What is Baird Medical Investment Holdings Ltd's quality score?
- BDMD scores 41.91815976110489/100 (grade D) on a SEC-grounded quality model spanning value, growth, profitability, financial health and momentum.
Sources: SEC EDGAR (CIK 0001982444, latest POS AM filed 2026-05-22) · EODHD · as of 7/3/2026, 10:23:12 PM.
Research and education only — not financial advice. EDGAR is not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates; see Disclosures. Past performance does not guarantee future results. Do your own research.